FilingReader Intelligence
Epigral reports ₹160 crore Q1 profit, plans ₹400 crore fundraise
August 2, 2025 at 07:49 AM UTC•By FilingReader AI
Epigral Limited reported profit after tax of ₹160.41 crore on revenue of ₹606.54 crore for Q1 FY2026.
The board approved raising up to ₹400 crore through non-convertible debentures or other debt securities.
The company's expansion plans remain on track, with CPVC Resin capacity set to reach 1,50,000 TPA and Epichlorohydrin capacity to reach 1,00,000 TPA by H1FY27.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:EPIGRAL•Bombay Stock Exchange
News Alerts
Get instant email alerts when Epigral publishes news
Free account required • Unsubscribe anytime